Lung-MAP Infographics Illustrate How the Trial is Helping Patients
Multitarget screening can increase the ‘hit rate’ and provide for uninterrupted accrual. This, in turn, will create a path to approval for safer and more effective drugs, while replacing ineffective ones.
-Vali Papadimitrakopoulou, MD Anderson, Lung-MAP Co-Principal Investigator
